Nature, Published online: 18 February 2026; doi:10.1038/s41586-026-10135-0
Biochemical and structural studies show that the bacterial dGTPase CloA is activated by virally produced dTTP and inhibited by 5′-triphosphothymidyl-3′5′-thymidine produced by its regulatory partner CloB, and thereby balances antiviral defence and immune-mediated toxicity.
From Nature via this RSS feed
You must log in or # to comment.

